At the beginning of the 21st century, the business world is dynamic and complex and competition is globalized. Success rates in innovation in such a context are low. Only of innovative ideas are eventually successful. In the pharmaceutical industry, the success rate falls to 1 in 10,000. The requirements for handling innovations have increased in numerous ways: globalization of competition, explosion of technological knowledge, tech- nological fusion, decentralization of knowledge, escalation of research and development costs, reduction of innovation cycles, and acceleration of in- novation diffusion. .
